Skip to main content
SpringerLink
Log in

Supporting ‘Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer’

  • Letter to the Editor
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 16 September 2021

The Original Article was published on 20 January 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A Jr, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D, KEYNOTE-048 Investigators (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394(10212):1915–1928. https://doi.org/10.1016/S0140-6736(19)32591-7 (Epub 2019 Nov 1. Erratum in: Lancet. 2020 Jan 25;395(10220):272. Erratum in: Lancet. 2020 Feb 22;395(10224):564. Erratum in: Lancet. 2021 Jun 12;397(10291):2252. PMID: 31679945)

    Article  CAS  PubMed  Google Scholar 

  • Franzese C, Badalamenti M, Teriaca A, De Virgilio A, Mercante G, Cavina R, Ferrari D, Santoro A, Spriano G, Scorsetti M (2021) Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer. J Cancer Res Clin Oncol 147(5):1307–1313. https://doi.org/10.1007/s00432-021-03518-5 (Epub 2021 Jan 20 PMID: 33471186)

    Article  CAS  PubMed  Google Scholar 

  • Gogineni E, Rana Z, Vempati P, Karten J, Sharma A, Taylor P, Pereira L, Frank D, Paul D, Seetharamu N, Ghaly M (2020) Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer. Head Neck 42(10):2880–2886. https://doi.org/10.1002/hed.26342 (Epub 2020 Jul 21 PMID: 32691496)

    Article  PubMed  Google Scholar 

  • Iqbal MS, West N, Richmond N, Kovarik J, Gray I, Willis N, Morgan D, Yazici G, Cengiz M, Paleri V, Kelly C (2021) A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancer. Br J Radiol 94(1117):20200332. https://doi.org/10.1259/bjr.20200332 (Epub 2020 Sep 24. PMID: 32960652; PMCID: PMC7774675)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

    Muhammad Shahid Iqbal, Josef Kovarik, Rahul Patil & Charles Kelly

Authors
  1. Muhammad Shahid Iqbal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josef Kovarik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rahul Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muhammad Shahid Iqbal.

Ethics declarations

Conflict of interest

All authors declare that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iqbal, M.S., Kovarik, J., Patil, R. et al. Supporting ‘Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer’. J Cancer Res Clin Oncol 148, 527–528 (2022). https://doi.org/10.1007/s00432-021-03754-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-021-03754-9

Keywords

Search

Navigation